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The combination of mathematical 
modeling with imaging experiments helps 
to interpret how NF-κB signaling is 
controlled. 
Abstract 
A study by Cheng et al. in this issue of 
Science Signaling highlights the distinct 
single-cell signaling characteristics 
conferred by pathways mediated by the 
adaptor proteins MyD88 and TRIF in the 
TLR4-dependent activation of the 
transcription factor nuclear factor–κB (NF-
κB). 
Nuclear factor–κB (NF-κB) is a 
transcription factor that is intimately 
involved in the inflammatory response. 
Although it was initially thought to act as a 
regulator of the immunoglobulin κ 
enhancer within B cells (1), it is now 
known that NF-κB is ubiquitously 
expressed and tightly regulated in a cell 
type– and stimulus-specific manner (2). 
Indeed, NF-κB controls the transcriptional 
regulation of many genes, such as those 
induced in response to infections and 
cellular stress (3). Because of the wide-
ranging gene products that are regulated 
through NF-κB, it has been deemed a 
“master” regulator of inflammation (2). 
Activation of the transcription factor is 
controlled by two distinct signaling 
networks, which have been termed the 
canonical and noncanonical pathways. The 
canonical pathway is activated through 
Toll-like receptors (TLRs) and by the 
interleukin-1 receptor (IL-1R) 
superfamily. Signaling is mediated through 
interactions between the cytoplasmic 
Toll/IL-1R (TIR) homology domain and 
downstream adaptor proteins, including 
myeloid differentiation primary response 
gene 88 (MyD88) and TIR domain–
containing adaptor gene inducing 
interferon-β (TRIF) (4). 
A substantial body of knowledge 
has been generated through traditional 
“wet” laboratory experimentation since the 
discovery of NF-κB almost 30 years ago. 
However, the complexity of the 
inflammatory process has been difficult to 
investigate through reductionist and linear 
analysis alone, because the dynamics of 
NF-κB signaling are characterized by 
nonlinear kinetics as well as numerous 
feedback loops. To obtain detailed 
information about the mechanisms 
controlling the NF-κB regulatory network, 
studies have increasingly used 
computational models, termed 
computational systems biology (5), to 
complement traditional wet-lab 
techniques. These studies use 
computational analysis to generate 
hypotheses about the mechanistic behavior 
of the signaling pathway. The in silico–
derived hypotheses help further our 
understanding of the dynamics of the 
biological system by predicting how 
activation at the level of the receptor 
complex is propagated down the signal 
transduction pathway(s), and they improve 
our knowledge of the hierarchy and 
significance of the individual regulatory 
steps. 
A large number of computational 
models about NF-κB signaling dynamics 
have been developed over the past 15 
years, which we have recently reviewed 
(6). The first widely used model was 
developed in 2002 by Hoffmann et al. (7), 
and since then, the Hoffmann group has 
extensively used a computational systems 
biology approach to further our 
understanding of NF-κB dynamics. Their 
latest study, by Cheng et al. (8) in this 
issue of Science Signaling, describes the 
distinct signaling characteristics conferred 
by the MyD88-controlled and TRIF-
dependent pathways in the TLR4-
stimulated activation of NF-κB. 
Cheng et al. performed a 
combination of in vitro and in silico 
experimentation to understand the 
specificity and redundancy between the 
MyD88-controlled and TRIF-dependent 
pathways in the activation of NF-κB (Fig. 
1). The authors first developed a 
mathematical model of TLR4 signaling 
that comprised three distinct functional 
modules: a TLR4 module for transduction 
of the extracellular signal into the 
activities of the downstream kinases IKK 
kinase (IKKK) and TANK-binding kinase 
1 (TBK1) through the MyD88 and TRIF 
pathways; an interferon response factor 
(IRF) module, which transduces TBK1 
activity to phosphorylated nuclear IRF3; 
and an existing NF-κB module, which has 
been extensively tested and refined since 
its initial development (6, 7). Subsequent 
in vitro experimentation focused on the 
activation dynamics of IKK in response to 
the TLR4 ligand lipopolysaccharide (LPS) 
in bone marrow–derived macrophages 
derived from wild-type, Myd88−/−, and 
Trif−/− mice, together with analysis of NF-
κB dynamics [as measured by 
electrophoretic mobility shift assay 
(EMSA)] and the dynamics of IRF3 
phosphorylation (as measured by Western 
blotting analysis). 
Initial in silico experimentation 
with the mathematical model, calibrated to 
these in vitro dynamics, was unable to 
recapitulate the EMSA-determined NF-κB 
activity profiles, and single-cell dynamics 
were obscured by a high degree of cell-to-
cell variability. The authors resolved this 
discrepancy by recalibrating the model 
parameters with single-cell NF-κB 
translocation dynamics gained through 
live-cell imaging of LPS-stimulated 
macrophages. This newly calibrated model 
was then used to explore the specific 
control of the MyD88- and TRIF-regulated 
pathways, including the role of endosome 
translocation, in encoding NF-κB 
dynamics. 
This combination of approaches 
enabled the authors to develop a predictive 
understanding of how TLR4-responsive 
NF-κB dynamics in populations of single 
cells were encoded by MyD88 and TRIF. 
In particular, the authors observed 
(through flux analysis and single-cell 
imaging) that receptor endocytosis 
generated temporal separation between the 
activation of NF-κB through both 
pathways; with the delayed activation 
through TRIF signaling ensuring that the 
initial first peak in NF-κB activation is 
dependent on MyD88 signaling. 
Additionally, the authors observed 
molecular noise regarding NF-κB 
activation by LPS and endosome 
maturation, which they believe was a 
result of extrinsic variation. After 
performing in silico experimentation to 
simulate this behavior, the authors 
conjectured that this extrinsic noise was 
the driving force for the variability of 
single-cell responses. 
We believe that the work of Cheng 
et al. in this issue of Science Signaling 
exemplifies the benefits that a 
computational systems biology approach 
can bring to furthering our understanding 
of complex signaling networks, such as 
those controlling NF-κB activity. We also 
believe that with the growing number of 
computational models that look at varying 
aspects of NF-κB signaling dynamics and 
that consider an increasing number of 
parameters (such as individual 
extracellular stimuli and gene 
transcriptional regulation), there is 
potential to merge these into a much larger 
system-wide model, which would enable 
us to simulate the signaling crosstalk that 
is inherent in complex biological systems. 
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Fig. 1. TLR4 signaling through the 
MyD88-controlled and TRIF-dependent 
pathways. MyD88 is an essential adaptor 
protein for the canonical NF-κB signaling 
pathway, which leads to the early-phase 
NF-κB–dependent production of 
inflammatory cytokines. Conversely, the 
adaptor protein TRIF leads to the IRF3-
induced and late-phase NF-κB–dependent 
activation (9) of the production of IFN-β. 
Although both pathways may be activated 
through TLR4 at the plasma membrane, 
the TRIF-dependent pathway may also be 
activated through endosomal induction. 
Additionally, the TRIF-dependent pathway 
links to the canonical pathway for the 
early-phase NF-κB–dependent production 
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